TUMORICIDAL CAPACITIES OF MACROPHAGES PHOTODYNAMICALLY ACTIVATED WITH HEMATOPORPHYRIN DERIVATIVE

Four days after administration to mice of small amounts (30–600ng/mouse) of hematoporphyrin derivative (HPD), peritoneal macrophages exhibited a greatly enhanced Fc‐receptor mediated phagocytic capacity as assayed by ingestion activity of IgG‐coated sheep erythrocytes. Much higher doses (>3000 ng/mouse) did not have this effect. The peritoneal macrophages activated by administration of HPD have tumoricidal capacity for IgG‐coated retinoblastoma cells. We then studied in vitro photodynamic activation of macrophages by white and red fluorescent light irradiation of mouse peritoneal cells (mixture of macrophages and B and T lymphocytes) in media containing very low concentrations of HPD. A short (5 s) white fluorescent light exposure (lWm‐2) of peritoneal cells in a medium containing 0.03 ng HPD/mL produced the maximal level of ingestion activity of macrophages. A 15 s red fluorescent light exposure (lWm‐Z) of peritoneal cells in a medium containing 0.1 ng HPD/mL produced the maximal level of ingestion activity of macrophages. Thus, photodynamic activation of macrophages with white fluorescent light is more efficient than that with red fluorescent light. This can be explained by the fact that HPD has a large absorption peak at about 364 nm which extends into the visible range, and decreasingly smaller absorption bands at 500, 535, 570 and 630 nm. In vitro photodynamically activated macrophages showed efficient tumoricidal activity regardless of the type (white or red) of light used. These results suggest that a low level of HPD promotes therapeutic immunopotentiation

[1]  R C Benson,et al.  Treatment of diffuse transitional cell carcinoma in situ by whole bladder hematoporphyrin derivative photodynamic therapy. , 1985, The Journal of urology.

[2]  T. Sery Photodynamic killing of retinoblastoma cells with hematoporphyrin and light. , 1979, Cancer research.

[3]  T. Dougherty Photodynamic therapy (PDT) of malignant tumors. , 1984, Critical reviews in oncology/hematology.

[4]  D. Shaw,et al.  Functional characteristics of the macrophage receptors for IgG-Fc and C3: failure to detect C3 receptor-mediated extracellular cytolysis by mouse peritoneal macrophages. , 1984, Cellular immunology.

[5]  T. Dougherty Photodynamic therapy. , 1993, Photochemistry and photobiology.

[6]  N. Yamamoto,et al.  Activation of mouse peritoneal macrophages by lysophospholipids and ether derivatives of neutral lipids and phospholipids. , 1987, Cancer research.

[7]  J K Hoober,et al.  Photodynamic immunopotentiation: in vitro activation of macrophages by treatment of mouse peritoneal cells with haematoporphyrin derivative and light. , 1991, European journal of cancer.

[8]  C. Elmets,et al.  Immunological suppression in mice treated with hematoporphyrin derivative photoradiation. , 1986, Cancer research.

[9]  R. Straight,et al.  SYSTEMIC IMMUNOSUPPRESSION INDUCED BY PHOTODYNAMIC THERAPY (PDT) IS ADOPTIVELY TRANSFERRED BY MACROPHAGES , 1989, Photochemistry and photobiology.

[10]  B. Bianco Alteration of Receptor Function upon Macrophage Activation , 1975 .

[11]  R. Straight,et al.  Systemic immunosuppression induced by peritoneal photodynamic therapy. , 1988, American journal of obstetrics and gynecology.

[12]  N. Yamamoto,et al.  Activation of peritoneal macrophages by lysophosphatidylcholine. , 1985, Biochimica et biophysica acta.

[13]  Z. Cohn,et al.  THE DIFFERENTIATION OF MONONUCLEAR PHAGOCYTES MORPHOLOGY, CYTOCHEMISTRY, AND BIOCHEMISTRY , 1965 .

[14]  H. Kato,et al.  Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer. , 1982, Chest.

[15]  R. Andreesen,et al.  Lysophosphatidylcholine (Lysolecithin) and its Synthetic Analogues. Immunomodulating and Other Biologic Effects , 1979 .

[16]  A. Girotti,et al.  Singlet oxygen intermediacy in the photodynamic action of membrane-bound hematoporphyrin derivative. , 1987, Cancer letters.

[17]  J. Farber,et al.  Accelerated phospholipid degradation and associated membrane dysfunction in irreversible, ischemic liver cell injury. , 1978, The Journal of biological chemistry.

[18]  S. Silverstein,et al.  Studies of the macrophage complement receptor. Alteration of receptor function upon macrophage activation , 1975, The Journal of experimental medicine.

[19]  H. Kato,et al.  Hematoporphyrin derivative and laser photoradiation in the diagnosis and treatment of bladder cancer. , 1983, The Journal of urology.

[20]  J. Marshall,et al.  EFFECT OF PHOTODYNAMIC THERAPY ON ANTITUMOR IMMUNE DEFENSES: COMPARISON OF THE PHOTOSENSITIZERS HEMATOPORPHYRIN DERIVATIVE AND CHLORO‐ALUMINUM SULFONATED PHTHALOCYANINE , 1989, Photochemistry and photobiology.

[21]  D. Kessel SITES OF PHOTOSENSITIZATION BY DERIVATIVES OF HEMATOPORPHYRIN , 1986, Photochemistry and photobiology.

[22]  J E Kaufman,et al.  Photoradiation therapy for the treatment of malignant tumors. , 1978, Cancer research.

[23]  M. Berns,et al.  Gynecologic uses of photoradiation therapy. , 1984, Progress in clinical and biological research.

[24]  C. Shields,et al.  The role of photocoagulation in the management of retinoblastoma. , 1990, Archives of ophthalmology.

[25]  J. Shields,et al.  Current approaches to the diagnosis and management of retinoblastoma. , 1981, Survey of ophthalmology.

[26]  N. Yamamoto,et al.  Contribution of Lysophosphatidylcholine-Treated Nonadherent Cells to Mechanism of Macrophage Activation , 1990, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[27]  S. Silverstein,et al.  SEGMENTAL RESPONSE OF THE MACROPHAGE PLASMA MEMBRANE TO A PHAGOCYTIC STIMULUS , 1974, The Journal of experimental medicine.

[28]  J. H. Kinsey,et al.  Treatment of transitional cell carcinoma of the bladder with hematoporphyrin derivative phototherapy. , 1983, The Journal of urology.